Menu
GWAS Study

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Kote-Jarai Z, Olama AA, Giles GG et al.

21743467 PubMed ID
GWAS Study Type
73609 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KZ
Kote-Jarai Z
OA
Olama AA
GG
Giles GG
SG
Severi G
SJ
Schleutker J
WM
Weischer M
CD
Campa D
RE
Riboli E
KT
Key T
GH
Gronberg H
HD
Hunter DJ
KP
Kraft P
TM
Thun MJ
IS
Ingles S
CS
Chanock S
AD
Albanes D
HR
Hayes RB
ND
Neal DE
HF
Hamdy FC
DJ
Donovan JL
PP
Pharoah P
SF
Schumacher F
HB
Henderson BE
SJ
Stanford JL
OE
Ostrander EA
SK
Sorensen KD
DT
Dörk T
AG
Andriole G
DJ
Dickinson JL
CC
Cybulski C
LJ
Lubinski J
SA
Spurdle A
CJ
Clements JA
CS
Chambers S
AJ
Aitken J
GR
Gardiner RA
TS
Thibodeau SN
SD
Schaid D
JE
John EM
MC
Maier C
VW
Vogel W
CK
Cooney KA
PJ
Park JY
CL
Cannon-Albright L
BH
Brenner H
HT
Habuchi T
ZH
Zhang HW
LY
Lu YJ
KR
Kaneva R
MK
Muir K
BS
Benlloch S
LD
Leongamornlert DA
SE
Saunders EJ
TM
Tymrakiewicz M
MN
Mahmud N
GM
Guy M
OL
O'Brien LT
WR
Wilkinson RA
HA
Hall AL
SE
Sawyer EJ
DT
Dadaev T
MJ
Morrison J
DD
Dearnaley DP
HA
Horwich A
HR
Huddart RA
KV
Khoo VS
PC
Parker CC
VA
Van As N
WC
Woodhouse CJ
TA
Thompson A
CT
Christmas T
OC
Ogden C
CC
Cooper CS
LA
Lophatonanon A
SM
Southey MC
HJ
Hopper JL
ED
English DR
WT
Wahlfors T
TT
Tammela TL
KP
Klarskov P
NB
Nordestgaard BG
RM
Røder MA
TA
Tybjærg-Hansen A
BS
Bojesen SE
TR
Travis R
CF
Canzian F
KR
Kaaks R
WF
Wiklund F
AM
Aly M
LS
Lindstrom S
DW
Diver WR
GS
Gapstur S
SM
Stern MC
CR
Corral R
VJ
Virtamo J
CA
Cox A
HC
Haiman CA
LM
Le Marchand L
FL
Fitzgerald L
KS
Kolb S
KE
Kwon EM
KD
Karyadi DM
OT
Orntoft TF
BM
Borre M
MA
Meyer A
SJ
Serth J
YM
Yeager M
BS
Berndt SI
MJ
Marthick JR
PB
Patterson B
WD
Wokolorczyk D
BJ
Batra J
LF
Lose F
MS
McDonnell SK
JA
Joshi AD
SA
Shahabi A
RA
Rinckleb AE
RA
Ray A
ST
Sellers TA
LH
Lin HY
SR
Stephenson RA
FJ
Farnham J
MH
Muller H
RD
Rothenbacher D
TN
Tsuchiya N
NS
Narita S
CG
Cao GW
SC
Slavov C
MV
Mitev V
ED
Easton DF
ER
Eeles RA
Chapter II

Abstract

Summary of the research findings

Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10(-8) to P = 2.7 × 10(-24)). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining ∼25% of the familial risk in this disease, have now been identified.

6,621 European ancestry cases, 6,939 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

73609
Total Participants
GWAS
Study Type
Yes
Replicated
22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls
Replication Participants
Other, East Asian, African American or Afro-Caribbean, European
Ancestry
U.S., Australia, U.K., Finland, Sweden, Poland, Bulgaria, Italy, Netherlands, Greece, Germany, Spain, Denmark
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.